Literature DB >> 4804287

Role of immunity in therapy of human cancer. Discussion.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4804287      PMCID: PMC2149045     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  7 in total

1.  "Tolerance" in postpartum female mice induced by strain-specific matings.

Authors:  E J BREYERE; M K BARRETT
Journal:  J Natl Cancer Inst       Date:  1960-03       Impact factor: 13.506

2.  [Blood clearance, distribution and chemotherapeutic trial of conjugates of sulfonamide-azo-anti-histoplasma gamma G globulins in the mouse].

Authors:  J C Jaton; H J Scholer; H Isliker
Journal:  Rev Fr Etud Clin Biol       Date:  1967-02

3.  Isolation of rabbit anti-rhesus lymphocyte antibody using a specific immunoadsorbent.

Authors:  B J Wilson; A Malley; M W Cook; B F Mackler
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

4.  Immunochemotherapy of cancer with chlorambucil-carrying antibody.

Authors:  T Ghose; S T Norvell; A Guclu; D Cameron; A Bodurtha; A S MacDonald
Journal:  Br Med J       Date:  1972-08-26

5.  Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.

Authors:  A J Cochran; W G Spilg; R M Mackie; C E Thomas
Journal:  Br Med J       Date:  1972-10-14

6.  THE EFFECT OF INTRAPERITONEAL INJECTION OF THORACIC DUCT LYMPHOCYTES FROM NORMAL AND IMMUNIZED RATS IN MICE INOCULATED WITH THE LANDSCHUTZ ASCITES TUMOUR.

Authors:  M F WOODRUFF; M O SYMES; N F ANDERSON
Journal:  Br J Cancer       Date:  1963-09       Impact factor: 7.640

7.  THE EFFECT OF RAT SPLEEN CELLS ON TWO TRANSPLANTED MOUSE TUMOURS.

Authors:  M F WOODRUFF; M O SYMES; A E STUART
Journal:  Br J Cancer       Date:  1963-06       Impact factor: 7.640

  7 in total
  1 in total

1.  DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer.

Authors:  Zenghua Deng; Mengmeng Xiao; Dexiao Du; Nan Luo; Dongfang Liu; Tingting Liu; Dongbo Lian; Jirun Peng
Journal:  Onco Targets Ther       Date:  2021-03-18       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.